Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Li

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Aging|November 19, 2024
A differentially-methylated-region signature predicts the recurrence risk for patients with early stage lung adenocarcinomaHeng Li, Fuchao Luo, Xiaoran Sun, et al.
Cryobiology|November 28, 2020
Optimization of UC-MSCs cold-chain storage by minimizing temperature fluctuations using an automatic cryopreservation systemYanhong Xu, Leo Li-Ying Chan, Siye Chen, et al.
Iscience|January 5, 2024
Notch activation defines immune-suppressive subsets of ccRCCs with unfavorable benefits from immunotherapy over VEGFR/mTOR inhibitorsSujun Han, Yu Xu, Dong Chen, et al.
Science China. Life Sciences|September 14, 2024
Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trialsJinliang Wang, Wenyong Zhou, Yu Xu, et al.
Aging|February 1, 2024
MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysisJin Tao, Jinshan Cui, Yu Xu, et al.
Aging|September 25, 2023
Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancerZheng Gong, Yuming He, Xiao Mi, et al.
Cancer Investigation|April 14, 2024
A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal AdenocarcinomaXiaofeng Sun, Hao Song, Xiaoran Sun, et al.
Journal of Fluorescence|September 22, 2023
Practical Characterization Strategies for Comparison, Qualification, and Selection of Cell Viability Detection Methods for Cellular Therapeutic Product Development and ManufacturingYongyang Huang, Rachel Watkins, Samir Patel, et al.
The Journal of Clinical Investigation|July 1, 2022
Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor modelsHaohai Zhang, Lili Feng, Paola de Andrade Mello, et al.
World Neurosurgery|July 22, 2022
The Influence of Facility Volume and Type on Skull Base Chordoma Treatment and OutcomesAmy T Du, Jonathan C Pang, Robert Victor, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Aging|November 19, 2024
A differentially-methylated-region signature predicts the recurrence risk for patients with early stage lung adenocarcinomaHeng Li, Fuchao Luo, Xiaoran Sun, et al.
Cryobiology|November 28, 2020
Optimization of UC-MSCs cold-chain storage by minimizing temperature fluctuations using an automatic cryopreservation systemYanhong Xu, Leo Li-Ying Chan, Siye Chen, et al.
Iscience|January 5, 2024
Notch activation defines immune-suppressive subsets of ccRCCs with unfavorable benefits from immunotherapy over VEGFR/mTOR inhibitorsSujun Han, Yu Xu, Dong Chen, et al.
Science China. Life Sciences|September 14, 2024
Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trialsJinliang Wang, Wenyong Zhou, Yu Xu, et al.
Aging|February 1, 2024
MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysisJin Tao, Jinshan Cui, Yu Xu, et al.
Aging|September 25, 2023
Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancerZheng Gong, Yuming He, Xiao Mi, et al.
Cancer Investigation|April 14, 2024
A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal AdenocarcinomaXiaofeng Sun, Hao Song, Xiaoran Sun, et al.
Journal of Fluorescence|September 22, 2023
Practical Characterization Strategies for Comparison, Qualification, and Selection of Cell Viability Detection Methods for Cellular Therapeutic Product Development and ManufacturingYongyang Huang, Rachel Watkins, Samir Patel, et al.
The Journal of Clinical Investigation|July 1, 2022
Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor modelsHaohai Zhang, Lili Feng, Paola de Andrade Mello, et al.
World Neurosurgery|July 22, 2022
The Influence of Facility Volume and Type on Skull Base Chordoma Treatment and OutcomesAmy T Du, Jonathan C Pang, Robert Victor, et al.
Pageof 10